Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byBio-Rad Laboratories
Date4/2014

General Information

Offices

Cambridge, USA
1 Kendall Square
Building 1400, Suite 14201
Cambridge, MA, 02139
USA

People

CFO
President & CEO & Co - Founder
VP, Informatics
VP, Molecular Biology
EVP, Product Development

Funding

TOTAL $22.5M
FUNDING TOTAL $22.5M
Series A, 12/2010
$3M
Series A, 9/2011
$5M
Grant, 9/2012
$4.5M
Series B, 10/2012
$10M

Tags

GnuBIO

GnuBIO is a leading developer of scalable DNA sequencing technology for both the Diagnostic and Applied markets. The GnuBIO technology is an emulsion-based microfluidic technology, which provides a scalable desktop sequencing system that allows interrogation of single genes, gene panels, and whole genomes. Using a proprietary DNA sequencing system, the GnuBIO’s platform encompasses all the steps required for DNA sequencing into a single platform including target selection and enrichment, DNA amplification, DNA sequencing and analysis. GnuBIO’s cutting-edge platform provides a single user interface, and a single step process, which rapidly produces results to hours versus days.

Recent Milestones

Videos

Screenshots

GnuBIO screenshot
Above: GnuBIO
Uploaded: 9/20/12

Sources

  1. Bio-Rad Buys GnuBio (finance.yahoo.com) [edit]
  2. Biomarker database startup GnuBio lands $3M (masshightech.com) [edit]
  3. SEC (sec.gov) [edit]
  4. GnuBIO gets $4.5M grant to advance DNA sequencing (masshightech.com) [edit]
  5. GnuBIO secures $10M in equity (masshightech.com) [edit]
Edit This Page
Last Edited 4/14/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy